Which category of TB was merged and is no longer used in the TB disease classification?
Appeared in: NORCERT 8 Mains-2025
Explanation
Under the Revised National Tuberculosis Control Programme (RNTCP) guidelines, Category-III was designated for new, smear-negative pulmonary TB cases that were not severely ill.
This category was officially discontinued to simplify treatment protocols.
Patients formerly classified under Category-III are now merged into Category-I and receive the same treatment regimen as other new TB cases.
This change ensures that all new TB patients receive a potent four-drug initial regimen, reducing the risk of treatment failure and drug resistance.
Why Other Options Were Wrong
Option A: Category-I was not merged or discontinued. Instead, it was expanded to include patients who were previously in Category-III.
Option B: Category-II was for previously treated patients (relapse, failure, default). While the classification system has evolved, the concept of a separate, more intensive approach for previously treated patients remains critical and has not been eliminated.
Option D: Category-IV was designated for chronic, drug-resistant cases (MDR-TB). This category has evolved into the comprehensive Programmatic Management of Drug-Resistant TB (PMDT), but the concept of managing drug-resistant TB as a separate, specialized group has been strengthened, not eliminated.
Related Visual
Visual 1: Flowchart: 'Evolution of TB Treatment Categories'. This visual would show the old RNTCP categories (I, II, III, IV) and how they transitioned to the current classification system (New, Previously Treated, Drug-Resistant), highlighting the merger of Category III into the 'New' patient group.
Clinical Relevance
Nursing practice connection: Knowing Classification and treatment categories of Tuberculosis under national programs helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Simplifying treatment protocols by eliminating Category-III reduces the chances of clinical error and ensures all new TB patients get the most effective first-line treatment.
This standardization is a key public health strategy to improve cure rates and prevent the emergence of drug resistance from under-treatment.
Nurses play a vital role in correctly identifying patients as 'new' or 'previously treated' to ensure they are started on the correct regimen from day one.
How to Approach the Question
First, identify the core of the question: it asks about a change in a medical classification system (for TB).
Recognize that such questions test your knowledge of current vs. outdated guidelines.
Recall the RNTCP/NTEP categories for TB. The main groups are based on new vs. previously treated status and drug susceptibility.
Consider each option: Category I (new cases), Category II (retreatment), Category III (milder new cases), and Category IV (MDR-TB).
Remember the public health principle of simplifying and strengthening treatment. The weakest regimen was for Category III. To improve outcomes, this category was eliminated, and all new patients were given the stronger Category I regimen. This identifies Category-III as the one that was merged and is no longer used.
Concept Tested & Keywords
Concept Tested: Classification and treatment categories of Tuberculosis under national programs.
Stem keywords: TB, disease classification, merged, no longer used
Lead-in keywords: Which
Negative lead-in flag: false
Question ID
QAO7qr0N8vprbhfaGDOrTx
Practise the full NORCERT 8 Mains-2025
Attempt every question from this paper in a timed mock, then review the full solution for each one.